Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Peripartum cardiomyopathy and Coronavirus Disease 2019 (COVID-19) associated cardiomyopathy: case series and review of literature
  • +3
  • Maryam Dehghan,
  • Mohammad Fakhrolmobasheri,
  • Tetsuya Kawakita,
  • Sadegh Mazaheri-tehrani,
  • Aref Rastegar,
  • Leila Mousavi Seresht
Maryam Dehghan
Isfahan University of Medical Sciences
Author Profile
Mohammad Fakhrolmobasheri
Isfahan Cardiovascular Research Center
Author Profile
Tetsuya Kawakita
University of Virginia Department of Obstetrics and Gynecology
Author Profile
Sadegh Mazaheri-tehrani
Isfahan University of Medical Sciences
Author Profile
Aref Rastegar
University of Virginia Department of Obstetrics and Gynecology
Author Profile
Leila Mousavi Seresht
Isfahan University of Medical Sciences

Corresponding Author:[email protected]

Author Profile

Abstract

Purpose: Peripartum cardiomyopathy (PPCM) is a rare complication of pregnancy manifesting with acute cardiac failure. Coronavirus Disease 2019 (COVID-19) can be complicated by cardiomyopathy, which can be difficult to differentiate from PPCM. The aim of this publication is to investigate different outcomes of cases with cardiomyopathy during pregnancy. Methods: Here, we report 4 peripartum cases with COVID-19 and acute cardiac failure due to cardiomyopathy. Moreover, to find previous similar cases, a comprehensive review on PPCM and COVID-19 associated cardiomyopathy was conducted in PubMed, Scopus, Embase, and Google Scholar. Results: Out of 4 cases we had, two cases deceased and one became a candidate for heart transplant. Despite advanced diagnostic approaches, differentiating COVID-19 associated cardiomyopathy from PPCM was challenging. According to the literature review, 7 cases with similar conditions were found. Conclusion: Pregnant women with COVID-19 may develop acute cardiac failure associated with PPCM or COVID-19 associated cardiomyopathy or both. This condition may be deadly due to rapid disease progression, atypical manifestations, and limited treatment options.
15 Apr 2022Submitted to Echocardiography
25 Apr 2022Submission Checks Completed
25 Apr 2022Assigned to Editor
03 May 2022Reviewer(s) Assigned
29 May 2022Review(s) Completed, Editorial Evaluation Pending
30 May 2022Editorial Decision: Revise Minor
08 Jun 20221st Revision Received
09 Jun 2022Submission Checks Completed
09 Jun 2022Assigned to Editor
09 Jun 2022Reviewer(s) Assigned
01 Jul 2022Review(s) Completed, Editorial Evaluation Pending